MDCLF
Price:
$6.976
Market Cap:
$859.85M
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraceptio...[Read more]
Industry
Biotechnology
IPO Date
2021-01-05
Stock Exchange
OTC
Ticker
MDCLF
According to MedinCell S.A.’s latest financial reports and current stock price. The company's current ROE is 64.48%. This represents a change of 157.92% compared to the average of 25.00% of the last 4 quarters.
The mean historical ROE of MedinCell S.A. over the last ten years is 34.05%. The current 64.48% ROE has changed 89.38% with respect to the historical average. Over the past ten years (40 quarters), MDCLF's ROE was at its highest in in the September 2021 quarter at 722.24%. The ROE was at its lowest in in the March 2019 quarter at -157.89%.
Average
34.05%
Median
78.46%
Minimum
-315.35%
Maximum
185.52%
Discovering the peaks and valleys of MedinCell S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 204.42%
Maximum Annual ROE = 185.52%
Minimum Annual Increase = -488.23%
Minimum Annual ROE = -315.35%
| Year | ROE | Change |
|---|---|---|
| 2025 | 112.65% | 83.68% |
| 2024 | 61.33% | -18.96% |
| 2023 | 75.68% | -59.20% |
| 2022 | 185.52% | -186.97% |
| 2021 | -213.32% | -242.35% |
| 2020 | 149.86% | -147.52% |
| 2019 | -315.35% | -488.23% |
| 2018 | 81.23% | -46.81% |
| 2017 | 152.70% | 204.42% |
The current ROE of MedinCell S.A. (MDCLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
83.22%
5-year avg
44.37%
10-year avg
34.05%
MedinCell S.A.’s ROE is greater than BioInvent International AB (publ) (-41.14%), greater than Avacta Group Plc (-43.42%), greater than Healios K.K. (-342.79%), greater than Race Oncology Limited (-26.07%), less than PureTech Health plc (12.82%), less than GenSight Biologics S.A. (54.11%), less than Northwest Biotherapeutics, Inc. (92.80%), greater than Verano Holdings Corp. (-29.26%), less than CytoDyn Inc. (22.25%), greater than Immutep Limited (-38.87%),
| Company | ROE | Market cap |
|---|---|---|
| -41.14% | $216.40M | |
| -43.42% | $481.37M | |
| -342.79% | $344.26M | |
| -26.07% | $451.73M | |
| 12.82% | $406.03M | |
| 54.11% | $36.12M | |
| 92.80% | $357.44M | |
| -29.26% | $323.07M | |
| 22.25% | $403.39M | |
| -38.87% | $264.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MedinCell S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MedinCell S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MedinCell S.A.'s ROE?
How is the ROE calculated for MedinCell S.A. (MDCLF)?
What is the highest ROE for MedinCell S.A. (MDCLF)?
What is the 3-year average ROE for MedinCell S.A. (MDCLF)?
What is the 5-year average ROE for MedinCell S.A. (MDCLF)?
How does the current ROE for MedinCell S.A. (MDCLF) compare to its historical average?